| UHC UMR Medical and Drug | Rituximab (Riabni®, Rituxan®, Ruxience®, & Truxima®) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Roctavian® (Valoctocogene Roxaparvovec-Rvox) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Sacroiliac Joint Interventions - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Sensory Integration Therapy and Auditory Integration Training - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Sinus Surgeries and Interventions - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Sleep Studies - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Sodium Hyaluronate - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Spinal Fusion and Bone Healing Enhancement Products - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Spinal Fusion and Decompression - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Spinraza® (Nusinersen) - Commercial Medical Benefit Drug Policy | 2026-01-01 |